NCT05047510View on ClinicalTrials.gov

GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Anti-GPC3-IRDye800CW

Drug Injection: Anti-GPC3-IRDye800CW

Trial Locations (2)

Unknown

RECRUITING

Zhuhai People's Hospital, Zhuhai

RECRUITING

The Affiliated Hospital of Southwest Medical University, Luzhou

Sponsors
All Listed Sponsors
lead

Chinese Academy of Sciences

OTHER_GOV

NCT05047510 - GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter